2019 Lung Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 252 pages | ID: 2C60E9E902CEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Lung Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Lung Injury. It presents in-depth analysis of Lung Injury clinical trials across markets and companies. The research work is for providing complete understanding into trends in Lung Injury.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Lung Injury clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Lung Injury

The research work is prepared through extensive and continuous research on Lung Injury trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Lung Injury patients are identified
• The report includes panorama of Lung Injury clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Lung Injury clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Lung Injury Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Lung Injury Clinical Trials by Region
  2.2.2 Average Enrollment of Lung Injury Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Lung Injury Treatment, 2019

3. REGION WISE LUNG INJURY CLINICAL TRIALS

3.1 Asia Pacific Lung Injury Clinical Trials by Country
3.2 Europe Lung Injury Clinical Trials by Country
3.3 North America Lung Injury Clinical Trials by Country
3.4 Middle East and Africa Lung Injury Clinical Trials by Country
3.5 South and Central America Lung Injury Clinical Trials by Country

4. LUNG INJURY CLINICAL TRIAL TRENDS

4.1 Start Year wise Lung Injury Clinical Trials
4.2 Phase wise Lung Injury Clinical Trials
4.3 Trial Status wise Lung Injury Clinical Trials
4.4 Trial Type wise Lung Injury Clinical Trials

5. LUNG INJURY AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Lung Injury Trials by Year
5.2 Average Enrollment in Lung Injury Trials by Phase
5.3 Average Enrollment in Lung Injury Trials by Status
5.4 Average Enrollment in Lung Injury Trials by Type of Trial

6. COMPANIES PARTICIPATING IN LUNG INJURY CLINICAL TRIALS

6.1 Lung Injury Trials by Sponsor Type
6.2 Lung Injury Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Lung Injury Trials- Phase
7.2 Lung Injury Trials- Phase
7.3 Lung Injury Trials- Phase
7.4 Lung Injury Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Lung Injury Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Lung Injury Clinical Trials and Enrolment
Figure 5: Europe – Country wise Lung Injury Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Lung Injury Clinical Trials and Enrolment
Figure 7: North America – Country wise Lung Injury Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Lung Injury Clinical Trials and Enrolment
Figure 9: Lung Injury Clinical Trials by Phase
Figure 10: Lung Injury Clinical Trials by Trial Status
Figure 11: Lung Injury Clinical Trials by Type
Figure 12: Lung Injury Clinical Trials by Sponsor Type
Figure 13: Lung Injury Clinical Trials by Leading Sponsors
Figure 14: Lung Injury Average Enrollment by Phase
Figure 15: Lung Injury Average Enrollment by Trial Status
Figure 16: Lung Injury Average Enrollment by Type
Figure 17: Lung Injury- Average Enrolment by Type of Sponsors
Figure 18: Lung Injury- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Lung Injury Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Lung Injury Clinical Trials and Enrolment
Table 5: Europe – Country wise Lung Injury Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Lung Injury Clinical Trials and Enrolment
Table 7: North America – Country wise Lung Injury Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Lung Injury Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Lung Injury Average Enrollment by Phase
Table 15: Lung Injury Average Enrollment by Trial Status
Table 16: Lung Injury Average Enrollment by Type
Table 17: Lung Injury- Average Enrolment by Type of Sponsors
Table 18: Lung Injury- Enrolment by Leading Sponsors